NCT04305899View on ClinicalTrials.gov

A Study to Compare the Taste and Levels in Blood Plasma of BMS-986165 When Taken as Different Formulations by Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2020

Primary Completion Date

November 25, 2020

Study Completion Date

November 25, 2020

Conditions
Healthy Participants
Interventions
DRUG

BMS-986165 Tablet formulation 1

Specified dose on specified days

DRUG

BMS-986165 Tablet formulation 2

Specified dose on specified days

Trial Locations (1)

66219

PRA Health Sciences - Lenexa, Lenexa

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY